A phase 1 dose‐escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma

Saved in:
Bibliographic Details
Published in:British journal of haematology 2015-03, Vol.168 (6), p.902-904
Main Authors: Kumar, Anita, Blum, Kristie A., Fung, Henry C., Smith, Mitchell R., Foster, Paul A., Younes, Anas
Format: Article
Language:English
Subjects:
Adult
Antibodies, Monoclonal, Humanized - administration & dosage
Antineoplastic Agents - administration & dosage
clinical trials
Dose-Response Relationship, Drug
Female
Hodgkin Disease - drug therapy
Hodgkin lymphoma
Humans
immunotherapy
Male
Middle Aged
monoclonal antibodies
Recurrence
therapy
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.13152